What Researchers Did
Chinese researchers reviewed the scientific literature on how HBOT affects the brain in diseases like Alzheimer's, Parkinson's, and ALS, looking at mechanisms including how it affects mitochondria, inflammation, and cell survival.
What They Found
HBOT has shown benefits in animal models and some clinical studies for multiple neurodegenerative conditions. It appears to work by improving energy production in brain cells, reducing inflammation, stimulating new neuron growth, reducing damaging oxidative stress, and improving blood flow in tiny brain vessels.
What This Means for Canadian Patients
Neurodegenerative diseases affect hundreds of thousands of Canadians and have very limited effective treatments. This review identifies HBOT as a therapy worth investigating more seriously for slowing cognitive decline and neurological damage in these conditions.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
Many of the supporting studies cited are in animals, and this review is from a Chinese-language journal, which may limit the breadth of literature reviewed.